Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | ATM | Q13315 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | OGG1 | O15527 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6652012 | 0.99 | KDM4E (0.58) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL17960334 | 0.88 | LMNA (0.58) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL6320278 | 0.83 | L3MBTL1 (0.49) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL6313363 | 0.83 | KDM4E (0.58) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL5371520 | 0.77 | KDM4E (0.66) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL15698898 | 0.76 | LMNA (0.61) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL4333252 | 0.76 | ALDH1A1 (0.60) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL31538574 | 0.76 | ALDH1A1 (0.60) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL1101766 | 0.75 | KDM4E (1.00) | KDM4EALDH1A1MAPTGAAHSD17B10 | |
| SCHEMBL30173777 | 0.75 | KDM4E (1.00) | KDM4EALDH1A1MAPTGAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0817635-B1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER LAMBERT CO (US) | 2004-06-16 | — | — | EP | disclosed |
| EP-0749434-B1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER LAMBERT CO (US) | 1999-12-15 | — | — | EP | disclosed |
| EP-0817635-A1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER-LAMBERT COMPANY LLC (US) | 1998-01-14 | — | — | EP | disclosed |
| US-5612330-A | HERPES VIRUS | WARNER-LAMBERT COMPANY (US) | 1997-03-18 | — | — | US | disclosed |
| EP-0749434-A1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER-LAMBERT COMPANY (US) | 1996-12-27 | — | — | EP | disclosed |
| US-5565446-A | USEFUL IN TREATMENT OF INFLAMMATORY DISEASES | WARNER-LAMBERT COMPANY (US) | 1996-10-15 | — | — | US | disclosed |
| WO-1996029077-A1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER-LAMBERT COMPANY (US) | 1996-09-26 | — | — | WO | disclosed |
| US-5489586-A | BENZOTHIOPHEN, BENZOFURAN AND INDOLE-THIAZEPINONES, OXAZEPINONES AND DIAZEPINONES | WARNER-LAMBERT COMPANY (US) | 1996-02-06 | — | — | US | disclosed |
| WO-1995024408-A1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER-LAMBERT COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |